Hospital de Cancer de Barretos - Fundacao Pio XII

Academic/Hospital

Also known as: Hospital de Cancer de Barretos - Fundacao Pio XII | Hospital do Cancer de Barretos - FundaÃ§Ã£o PIO XII | Hospital do Cancer de Barretos Fundacao Pio XII

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 2013

Last known activity

Nov 1, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

imiquimod

Phase 3 (1 own, 0 via acquisition)

tanezumab

Phase 2 (4 own, 0 via acquisition)

irinotecan
gemcitabine
proflavine
cisplatin

Indications

Studied for

Biliary Tract Neoplasms
Cancer Pain
Musculoskeletal Pain
Neoplasm Metastasis

Recent trials (4)

NCT06435286CollaboratorPhase 2Nov 1, 2024
NCT06356012CollaboratorPhase 4Apr 2, 2024
NCT02609828Overall official - principal investigatorPhase 3Oct 28, 2015
NCT01859728Lead sponsorPhase 2Jan 1, 2013

Details

Last known activity: Nov 1, 2024